CXCL12 and familial pancreatic carcinoma: Taken together, our present work provides solid evidence for reciprocal interactions between CAFs and pancreatic cancer cells, shedding new light on the utilization of the SDF-1/CXCR4/SATB-1 axis as a potential therapeutic target for the treatment of pancreatic cancer.